These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6242959)

  • 1. Time of onset and duration of activity of piroxicam in rheumatoid arthritis: a placebo controlled study.
    Tausch G
    Eur J Rheumatol Inflamm; 1981; 4(3):368-75. PubMed ID: 6242959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dynamics of the joint pains at night in rheumatoid arthritis and arthroses treated with Rengasil and piroxicam].
    Malaia LT; Liashenko MM; Brigidina VIa
    Farmakol Toksikol; 1986; 49(6):83-7. PubMed ID: 3545900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind cross-over comparison of piroxicam and indomethacin in the treatment of rheumatoid arthritis.
    Davies J; Dixon AS; Ring EF
    Eur J Rheumatol Inflamm; 1981; 4(3):314-7. PubMed ID: 6242952
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analgesic effectiveness of Felden (piroxicam) in chronic polyarthritis. A placebo controlled study].
    Tausch G
    Wien Med Wochenschr; 1980; 130 Spec No():57-61. PubMed ID: 7456467
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of piroxicam with naproxen in rheumatoid arthritis: a double-blind, cross-over, multicentre study.
    Sydnes OA
    Eur J Rheumatol Inflamm; 1981; 4(3):318-22. PubMed ID: 6242953
    [No Abstract]   [Full Text] [Related]  

  • 6. Piroxicam in the treatment of rheumatoid arthritis.
    Grewin B
    Eur J Rheumatol Inflamm; 1981; 4(3):332-5. PubMed ID: 6242954
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the efficacy, safety, and pharmacokinetic profiles of extended-release ketoprofen and piroxicam in patients with rheumatoid arthritis.
    Caldwell JR
    Clin Ther; 1994; 16(2):222-35. PubMed ID: 8062318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long term study on the efficacy and safety of lornoxicam in rheumatoid arthritis].
    Frizziero L; Focherini MC; Valentini M; Reta M; Rocchi P
    Minerva Med; 2002 Aug; 93(4):315-20. PubMed ID: 12207202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trails of piroxicam suppositories in the therapy of rheumatoid arthritis].
    Iwata H; Nakajima M; Nobenaga T
    Ryumachi; 1987 Apr; 27(2):147-55. PubMed ID: 3317919
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and laboratory changes produced by piroxicam in rheumatoid arthritis.
    De Zubiria RC; Charria A; Lobo Guerrero D
    Eur J Rheumatol Inflamm; 1983; 6(1):56-62. PubMed ID: 6861814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily piroxicam in rheumatoid arthritis: a double-blind cross-over comparison with aloxiprin.
    Roberts SD; Vir C; Porter KG
    Eur J Rheumatol Inflamm; 1981; 4(3):323-31. PubMed ID: 6086096
    [No Abstract]   [Full Text] [Related]  

  • 14. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
    Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
    Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis.
    Walsh JK; Muehlbach MJ; Lauter SA; Hilliker NA; Schweitzer PK
    J Rheumatol; 1996 Feb; 23(2):245-52. PubMed ID: 8882027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis.
    Domljan Z; Durrigl T
    Eur J Rheumatol Inflamm; 1983; 6(3):291-6. PubMed ID: 6391934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in lipid, peroxide, and anti-oxidant blood levels during piroxicam (Hotemin) treatment.
    Bartosiewicz G; Mézes M; Német J
    Ther Hung; 1993; 41(2):67-71. PubMed ID: 8278941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diclofenac and piroxicam in a double-blind trial results and methodological problems. Working Party of the Society for Rheumatology of the GDR for the Testing of Anti-rheumatic Drugs.
    Keitel W; Friedländer R; Häntzschel H; Hüge W; Keysser M; Seidel W; Tanner E; Wächter G; Weber J; Wille R
    Eur J Rheumatol Inflamm; 1984; 7(3):105-13. PubMed ID: 6400520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Piroxicam in degenerative joint diseases (arthroses) in orthopedics].
    Schwägerl W
    Wien Med Wochenschr; 1980; 130 Spec No():53-7. PubMed ID: 7456466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.